rs786205225
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001135998.3(NDUFB11):c.262C>T(p.Arg88*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001135998.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- linear skin defects with multiple congenital anomalies 3Inheritance: XL Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- mitochondrial complex I deficiency, nuclear type 30Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- linear skin defects with multiple congenital anomaliesInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Linear skin defects with multiple congenital anomalies 3 Pathogenic:1Other:1
- -
- -
Histiocytoid cardiomyopathy Pathogenic:1
- -
Linear skin defects with multiple congenital anomalies 1;C4225421:Linear skin defects with multiple congenital anomalies 3;CN257533:Mitochondrial complex I deficiency, nuclear type 1 Pathogenic:1
- -
not provided Pathogenic:1
The R88X variant in the NDUFB11 gene has been reported previously as a de novo change in twofemale patients, one with MLS syndrome and histiocytoid cardiomyopathy in whom R88X wasidentified in the mosaic state in lymphocytes (van Rahden et al., 2015), and another with histiocytoidcardiomyopathy who lacked diagnostic features of MLS (Rea et al., 2016a; Rea et al., 2016b). Thisvariant is predicted to cause loss of normal protein function either through protein truncation ornonsense-mediated mRNA decay. The R88X variant was not observed in approximately 6500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. We interpret R88X as a pathogenicvariant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at